Scalabrino (2021) stated that recent findings show that EGF expression was significantly decreased in the cerebrospinal fluid (CSF) and SC of the MS patients, and the new information about the role of EGF in MS required a critical reassessment of the MS pathogenesis. The gene discussed is EGF; the disease is myeloid sarcoma.